Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-321,715
Closed -$113M – 4109
2026
Q1
$113M Buy
+321,715
New +$115M 0.28% 49
2025
Q2
– Sell
-28,553
Closed -$8.09M – 2542
2025
Q1
$8.89M Buy
+28,553
New +$8.43M 0.06% 267
2024
Q3
– Sell
-13,439
Closed -$4.2M – 2363
2024
Q2
$4.2M Buy
+13,439
New +$3.95M 0.02% 444
2024
Q1
– Sell
-33,164
Closed -$9.55M – 2254
2023
Q4
$9.55M Buy
+33,164
New +$9.04M 0.07% 168
2023
Q3
– Sell
-16,255
Closed -$3.61M – 2355
2023
Q2
$3.61M Buy
+16,255
New +$3.77M 0.03% 393
2023
Q1
– Sell
-138,789
Closed -$34.1M – 2447
2022
Q4
$36.5M Buy
+138,789
New +$37.2M 0.52% 24
2022
Q3
– Sell
-440,488
Closed -$107M – 2743
2022
Q2
$107M Buy
440,488
+403,127
+1,079% +$98.8M 1.17% 10
2022
Q1
$9.03M Sell
37,361
-32,317
-46% -$7.43M 0.06% 164
2021
Q4
$15.7M Buy
69,678
+26,333
+61% +$5.56M 0.09% 109
2021
Q3
$9.22M Sell
43,345
-60,230
-58% -$13.9M 0.06% 170
2021
Q2
$25.2M Buy
+103,575
New +$25.5M 0.23% 68
2020
Q2
– Sell
-9,805
Closed -$1.99M – 1514
2020
Q1
$1.99M Buy
+9,805
New +$2.14M 0.13% 158
2019
Q4
– Sell
-4,348
Closed -$841K – 1126
2019
Q3
$841K Sell
4,348
-23,001
-84% -$4.41M 0.04% 439
2019
Q2
$5.04M Buy
27,349
+19,615
+254% +$3.51M 0.32% 71
2019
Q1
$1.47M Sell
7,734
-18,315
-70% -$3.5M 0.23% 62
2018
Q4
$5.07M Buy
26,049
+20,090
+337% +$3.92M 0.72% 31
2018
Q3
$1.24M Buy
5,959
+3,452
+138% +$680K 0.19% 88
2018
Q2
$462K Buy
2,507
+469
+23% +$83K 0.17% 112
2018
Q1
$347K Buy
2,038
+773
+61% +$142K 0.17% 119
2017
Q4
$219K Buy
+1,265
New +$224K 0.22% 73
2015
Q4
– Sell
-3,456
Closed -$478K – 66
2015
Q3
$478K Buy
+3,456
New +$545K 0.41% 38

Other funds holding AMGN

HRT Financial's AMGN Position: Q2 2026 in Review

HRT Financial sold out of Amgen (AMGN) in Q2 2026, closing a stake of 321,715 shares — an estimated $113M sold.

HRT Financial first reported a position in AMGN in Q3 2015 and held it in 21 quarters. The position peaked at $113M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HRT Financial reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 321,715 Amgen shares in Q2 2026, an estimated $113M.
  • HRT Financial first reported a position in Amgen in Q3 2015 and held it in 21 quarters.
  • HRT Financial's Amgen position peaked at $113M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.